Details of the Drug

General Information of Drug (ID: DM5ZOUS)

Drug Name

CSL-889

Indication

Disease Entry	ICD 11	Status	REF
Sickle-cell disorder	3A51	Phase 1	[1]
------------------------------------------------------------------------------------

Drug Type

Protein

Cross-matching ID

References

1	ClinicalTrials.gov (NCT04285827) A 2-Part, Phase 1, Multi-Center, Single-Dose, Open Label, Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of CSL889 in Adult Patients With Sickle Cell Disease. U.S.National Institutes of Health.